Myriad Genetics, Inc. (MYGN)
4.29
+0.20
(+4.89%)
USD |
NASDAQ |
May 08, 16:00
4.285
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Total Assets (Quarterly) : 673.70M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 511.25M |
| Plus Therapeutics, Inc. | 16.32M |
| Perspective Therapeutics, Inc. | 274.34M |
| Atossa Therapeutics, Inc. | 37.94M |
| AVITA Medical, Inc. | 56.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 336.30M |
| Shareholders Equity (Quarterly) | 337.40M |
| Debt to Equity Ratio | 0.6269 |
| Current Ratio | 2.402 |
| Net Debt Paydown Yield | -3.35% |